Chemotherapy + PD-1/PD-L1 Blockade Should Be the Preferred Option in the Neoadjuvant Therapy of NSCLC

被引：4
|
作者：
Rosner, Samuel [1 ]
Forde, Patrick M. [1 ]
机构：
[1] Johns Hopkins Med Sidney Kimmel Comprehens Canc C, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD 21231 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 04期
关键词：
CELL LUNG-CANCER; OPEN-LABEL; NEOADJUVANT ATEZOLIZUMAB; SINGLE-ARM; MULTICENTER; RESECTION; IMMUNOTHERAPY; NIVOLUMAB; TRIAL;
D O I：
10.1016/j.jtho.2022.02.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：503 / 509
页数：7
相关论文
共 50 条
  • [1] Chemotherapy thorn PD-1/PD-L1 Blockade Should Not Be the Preferred Option in the Neoadjuvant Therapy of NSCLC
    Hendriks, Lizza E. L.
    Remon, Jordi
    Reck, Martin
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (04) : 499 - 502
  • [2] NEOADJUVANT PD-1 BLOCKADE IN NSCLC
    Killock, David
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (07) : 404 - 404
  • [3] Neoadjuvant PD-1 blockade in NSCLC
    David Killock
    [J]. Nature Reviews Clinical Oncology, 2018, 15 : 404 - 404
  • [4] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    [J]. ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [5] PD-1 and PD-L1 Blockade plus Chemotherapy in Endometrial Cancer
    Polak, Paz
    Fu, Lili
    Foulkes, William D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (09): : 866 - 868
  • [6] Oncolytic virus and PD-1/PD-L1 blockade combination therapy
    Chen, Chun-Yu
    Hutzen, Brian
    Wedekind, Mary F.
    Cripe, Timothy P.
    [J]. ONCOLYTIC VIROTHERAPY, 2018, 7 : 65 - 77
  • [7] PD-L1 Expression in Mucosal Malignant Melanoma: Implications for PD-1/PD-L1 Blockade Therapy
    Lilo, Mohammed
    Berry, Sneha
    Xu, Haiying
    Ogurtsova, Aleksandra
    Lipson, Evan
    Taube, Janis
    [J]. MODERN PATHOLOGY, 2015, 28 : 123A - 123A
  • [8] PD-L1 Expression in Mucosal Malignant Melanoma: Implications for PD-1/PD-L1 Blockade Therapy
    Lilo, Mohammed
    Berry, Sneha
    Xu, Haiying
    Ogurtsova, Aleksandra
    Lipson, Evan
    Taube, Janis
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 123A - 123A
  • [9] PD-L1 copy number gains: a predictive biomarker for PD-1/PD-L1 blockade therapy?
    Inoue, Yusuke
    Osman, Murat
    Suda, Takafumi
    Sugimura, Haruhiko
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S199 - S202
  • [10] Combining chemotherapy with PD-1 blockade in NSCLC
    Mathew, Matthen
    Enzler, Thomas
    Shu, Catherine A.
    Rizvi, Naiyer A.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2018, 186 : 130 - 137
12345